Biota Pharmaceuticals Announces Changes to Its Board of Directors
5/6/2013 9:28:12 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ATLANTA, May 6, 2013 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company"), a biopharmaceutical company focused on the discovery and development of anti-infective products to prevent and treat serious and potentially life-threatening infectious diseases, today announced changes to its Board of Directors, including the resignations of Dr. Raafat Fahim and Mr. Paul Bell, and the appointments of Ms. Anne M. VanLent and Mr. Michael R. Dougherty to fill those vacancies. Ms. VanLent will serve as Chair of the Audit Committee.
Help employers find you! Check out all the jobs and post your resume.